To validate the feasibility of using Bmi1 as a potential target for HCC treatment, here, we report that knockdown of Bmi1 gene inhibits HCC cell proliferation in vitro and in vivo, both in the onset periods and the fast growing periods of the neoplasm. Here, BMI1 is linked to hepatocellular carcinoma.